In the highly regulated world of pharmaceutical manufacturing, the quality of every raw material and intermediate directly impacts the safety and efficacy of the final drug product. Ethyl 2-oxo-4-phenylbutyrate (CAS 64920-29-2) is no exception. As a crucial pharmaceutical intermediate, its specifications are rigorously defined and must be met by any reputable manufacturer and supplier. Understanding these specifications is key for any entity looking to purchase this compound.

The primary specification for pharmaceutical-grade Ethyl 2-oxo-4-phenylbutyrate is its purity. Typically, a purity level of ≥95.0% is required. This high purity ensures that the intermediate contains minimal by-products or residual solvents that could interfere with subsequent synthesis steps or, more importantly, introduce unwanted impurities into the API. Impurities in pharmaceutical intermediates can lead to reduced drug effectiveness, adverse patient reactions, and regulatory non-compliance. Therefore, a meticulous purification process is essential.

Beyond purity, other critical quality parameters for Ethyl 2-oxo-4-phenylbutyrate include its physical appearance, which is consistently described as a light yellow oily liquid. This visual cue serves as an initial check for product integrity. Chemical identity is confirmed through analytical techniques like NMR (Nuclear Magnetic Resonance) and Mass Spectrometry. Furthermore, parameters such as water content and the presence of specific related substances are monitored to ensure batch-to-batch consistency. Manufacturers often provide a Certificate of Analysis (CoA) detailing these specifications for each batch supplied.

The role of Ethyl 2-oxo-4-phenylbutyrate in synthesizing critical drugs like Lisinopril (an ACE inhibitor) and Cilastatin (an antibiotic enhancer) makes adherence to these specifications non-negotiable. The precision required in these syntheses demands intermediates that are not only pure but also chemically consistent. When sourcing from China, it is imperative to partner with manufacturers who are transparent about their quality control processes and can provide comprehensive documentation to verify that their Ethyl 2-oxo-4-phenylbutyrate meets all necessary pharmaceutical standards. We pride ourselves on being such a reliable supplier, offering competitive prices and unwavering quality.

In conclusion, the stringent specifications for Ethyl 2-oxo-4-phenylbutyrate are fundamental to ensuring the quality and safety of essential pharmaceutical products. Pharmaceutical companies must prioritize sourcing from manufacturers who demonstrate a strong commitment to quality control and regulatory compliance. By choosing a trusted manufacturer and supplier, you secure a vital component for your drug development and production pipelines, ultimately contributing to better patient outcomes.